NCT00858780 - Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RA | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Etanercept

50 mg etanercept once weekly + methotrexate

DRUG

Etanercept

25mg etanercept once weekly + methotrexate

DRUG

Placebo

Placebo comparator once weekly + methotrexate

Trial Locations (16)

108

Pfizer Investigational Site, Reykjavik

2609

Pfizer Investigational Site, Lillehammer

2900

Pfizer Investigational Site, Hellerup

5021

Pfizer Investigational Site, Bergen

5701

Pfizer Investigational Site, Gyula

8200

Pfizer Investigational Site, Veszprém

9700

Pfizer Investigational Site, Szombathely

14186

Pfizer Investigational Site, Stockholm

17176

Pfizer Investigational Site, Stockholm

40620

Pfizer Investigational Site, Jyväskylä

DK-2600

Pfizer Investigational Site, Glostrup Municipality

FI-00029 HUS

Pfizer Investigational Site, Helsinki

0319

Pfizer Investigational Site, Oslo

221 85

Pfizer Investigational Site, Lund

SE-205 02

Pfizer Investigational Site, Malmo

751 85

Pfizer Investigational Site, Uppsala